Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
American Oncology Network (AON), associated with the symbol AONC, appears frequently in public news releases as a rapidly growing community oncology network. These announcements highlight how AON partners with community-based oncology and hematology practices across multiple states, bringing together physicians and healthcare leaders focused on delivering cancer care close to where patients live and work.
News about American Oncology Network often covers the expansion of its national network, including new partner practices, new clinic locations, and the recruitment of additional board-certified medical oncologists and hematologists. Releases describe practices in states such as Arkansas, Maryland, Texas, and Hawai’i joining or expanding within the network, illustrating AON’s emphasis on community-based care.
Another recurring theme in AON-related news is the development of advanced clinical capabilities and research. Examples include the growth of radiotheranostic and radioligand therapy services at partner practices, the appointment of a radiology medical director and in-house reading radiologist, and the activities of American Oncology Research (AOR), which supports clinical trials in the community setting. AOR’s alliance with Meaningful Insights Biotech Analytics to integrate AI-enhanced data into clinical research within the American Oncology Network is also featured.
In addition, AON news items describe participation in national oncology meetings and research symposia, with multiple abstracts accepted at American Society of Clinical Oncology events. These stories focus on value-based care, cost of care, reimbursement, and social risk factors in oncology. Visitors to the AONC news page can expect coverage of network growth, physician additions, clinic openings, research collaborations, and initiatives aimed at improving access, quality, and equity in community oncology.
Elkhart Hematology and Oncology (formerly Elkhart Clinic’s hematology and oncology practice) joined American Oncology Network (AONC) on May 5, 2026, expanding patient access to clinical trials and community-based cancer care. The practice will continue onsite infusion, centralized lab/pathology, specialty pharmacy, care coordination and financial counseling.
Dr. Ahsanul Haque and Charisse Prall, FNP-BC will continue to lead clinical services and are accepting new patients.
MidAmerica Cancer Care (AONC) announced that Dr. Syed Karim, a board-certified medical oncologist and hematologist, has joined the physician team and is accepting new patients at the Belton location.
Dr. Karim brings more than 10 years of clinical experience in the Kansas City area and completed fellowships at George Washington University and Georgetown University Hospital. For more information visit maccsp.com and AONcology.com.
The Center for Cancer and Blood Disorders (AONC) received authorization to administer FDA-approved CAR T-cell therapy and has begun treating its first community oncology patient in the Maryland-area clinic as of April 23, 2026. The program offers outpatient CAR T and bispecific therapy access across Maryland, Washington, D.C., and Northern Virginia, led by Dr. Ralph Boccia and a multidisciplinary CCBD team. CCBD previously ran four outpatient CAR T trials and three outpatient bispecific trials, and coordinates closely with local hospitals to manage monitoring, safety, and follow-up care.
American Oncology Network (NYSE:AONC) will speak at the 2026 Community Oncology Alliance Annual Conference, April 28-29 in Orlando. AON leaders will deliver 11 sessions on topics including CAR T, radiopharmaceuticals, clinical trials, payer data, patient advocacy and careers in community oncology. AON will exhibit at booth 207.
Messino Cancer Centers (AONC) opened a new clinic in South Asheville on March 18, 2026, expanding to its sixth location at 1815 Hendersonville Road, Suite 103.
The clinic is open Tuesdays–Thursdays 8 AM–5 PM, includes an on-site lab, private exam rooms and an infusion suite with eight chairs; breast cancer care is available from Board-certified physicians Dr. Rachel Raab and Dr. Emily Miller.
Oncology Consultants (AONC) announced on March 5, 2026 that it has joined American Oncology Network (AON), expanding clinical trial access and operational resources while preserving its physician-led independence. The practice operates 18 locations across South Texas with 16 medical oncologists, 3 radiation oncologists and 23 advanced practitioners.
The partnership aims to enhance patient access to advanced therapies, reduce administrative burden, maintain local care delivery and support long-term sustainability for community-based oncology services.
American Oncology Network (AONC) partner practice Fort Wayne Medical Oncology and Hematology expanded services at Cameron Health in Angola, Indiana, effective March 4, 2026, to increase local access to comprehensive cancer care.
Renovations added an expanded lobby, dedicated registration, five new exam rooms, a private physician office and 12 infusion bays, plus support areas; the facility also recently installed a new linear accelerator. FWMOH will increase days of on-site medical oncology, hematology, infusion therapy and palliative/supportive services to serve rising cancer rates in Steuben County.
RKV Medical Center (AONC) in Muskogee, Oklahoma, joined American Oncology Network on Feb 4, 2026 as AON’s first partner practice in the state.
The partnership aims to expand access to clinical trials, advanced therapies, onsite infusion and radiation services, specialty pharmacy, centralized labs, and continued community-based care under Dr. Ravikumar Vasireddy.
Hematology Oncology of Indiana (AONC) announced that Dr. Amy Braden, DO, a board-certified medical oncologist and hematologist with over 10 years of experience, has joined its physician team and is accepting new patients as of February 3, 2026. Dr. Braden will see patients in Indianapolis, Logansport, and Noblesville.
The practice operates six locations across Indiana and offers specialty infusion, pathology, pharmacy, clinical trials, and BiTE therapy as part of community-based cancer care.
Genesis Cancer and Blood Institute (AONC) announced on Jan 21, 2026 the addition of board-certified endocrinologist Daryl Burrows, MD, and advanced practice nurse Natalie Brown, APRN to its Hot Springs team. The hires expand Genesis to offer onsite endocrinology alongside oncology across 11 Arkansas locations, enabling coordinated endocrine and cancer care at the Genesis Hot Springs—Higdon Ferry clinic.
The staff additions increase local access to diabetes and endocrine services within the community-based cancer practice.